rus, Toronto A 26/61, from dogs present in an outbreak. However, the authors could not exclude the possibility that the virus which resembled infectious canine hepatitis (ICH) virus was not of vaccine origin, since an ICH vaccine was given prior to the onset of the outbreak. Subsequently, additional reports have appeared associating canine respiratory disease with this adenovirus (2, 3) which although antigenically related to, was found to be serologically distinguishable from ICH virus.
Karpas et al. (4, 5 ) recovered a herpes virus, Herpes canis (6, 7) from ill as well as from healthy animals. Dogs exposed experimentally to it were reported to have developed signs of respiratory disease. Herpes canis virus also was recovered by Japanese workers (8) from a fatal case of canine pneumonia. The same virus has been found in cell cultures of normal canine kidney (9) (10) (11) .
Lou and Wenner (12) and Massie and Shaw (13) isolated a reovirus from ill dogs. The latter authors reported that they could induce clinical signs of disease with this virus but these results could not be confirmed by others in specific germ-free dogs (14) .
In isolation of a similar parainfluenza virus from sick dogs which, following intransal inoculation into two six-week-old puppies, produced mild signs of respiratory disease. Virus was isolated from each of the dogs and both showed rises in specific antibodies (16) . Since the present investigation was undertaken, several studies dealing with canine SV5-like viruses have appeared (17) (18) (19) . However, none of the authors could assess the actual role of the virus in natural outbreaks of kennel cough, although Appel and Percy (17) reported inducing respiratory disease in about 50 per cent of their experimentally inoculated dogs. In contrast, Black and Lee (19) stated that in 15 dogs successfully infected with a similar virus, no signs of respiratory disease were produced.
In September 1967, a parainfluenza virus related to SV5 virus, was recovered in our laboratories from the nasopharynx of a dog affected in a small outbreak of canine tracheobronchitis which occurred in the hospital of the University of Pennsylvania School of Veterinary Medicine. The purposes of the present study were: 1) to examine the infectivity and/or pathogenicity of this virus for dogs on introduction into the nasopharynx; 2) to determine whether an infection and/or disease thus established could be spontaneously transmitted in series to other dogs; 3) to follow the serum antibody responses of successfully infected animals and to evaluate the role of these antibodies in conferring protection; 4) to examine the prevalence of serum antibodies to this agent in a general canine population; and 5) to investigate the antigenic relationships existing between it and SV5 and other representative members of the paramyxovirus group.
MATERIALS AND METHODS
Test virus. The virus under study was isolated in primary cultures of canine kidney cells (PCK) and was designated Penn/343/67. After three passages in PCK cells it was propagated in Madin Darby caDownloaded from https://academic.oup.com/aje/article-abstract/94/2/147/167124 by guest on 10 January 2019 nine kidney (MDCK) cell cultures, where maximal infectivity titers (TCID 50 ) were reached after seven days incubation at 36 C.
The second passage in MDCK cells served as inocula for the dogs. Just before harvesting, gelatin to give a final concentration of 0.5 per cent was added to the Blake bottles containing the infected monolayers and medium. The contents were then rapidly frozen and thawed and centrifuged at 1000 rpm for 10 minutes. The clarified supernatant fluids, after filtration through a 0.45 Millipore filter, were used immediately for the dog inoculations and a portion subjected to infectivity titrations which were performed in MDCK cells in the usual manner (20) .
Reference viruses. Viruses used for the antigenic characterization of Penn/343/67 virus included SV5, parainfiuenza type 1 (PI-1,HA 2), Sendai (PI-1 muris), parainfiuenza type 2 (PI-2,CA), parainfiuenza type 3 (PI-3,HA 1), Newcastle disease (NDV) and mumps (Barnes strain) viruses, all of which were maintained as stock viruses in our laboratories. SV5, PI-2 and PI-3 viruses were propagated in cell cultures of rhesus monkey kidney (Lilly Laboratories Co. (LLC)-MK 2 ), PI-1 in African green monkey kidney (AGMK) monolayers and the remaining viruses in the allantois of embryonated chicken eggs. Seed viruses were stored at -85 C.
Cell cultures. PCK, MDCK, LLC-MK 2 and AGMK monolayers were grown in Eagle's minimal essential medium in Earle's buffered salt solution with the addition of 10 per cent fetal calf serum and 100 units of penicillin and 100 meg of streptomycin per ml. For maintenance the same medium was used but with 2 per cent calf serum instead of 10 per cent. Incubation was always carried out in the stationary position at 36 CBefore inoculation with virus the growth or maintenance medium was removed, the cell layers were washed twice with Earle's buffered salt solution and medium free of serum was added.
Experimental animals. Thirty-six dogs of mixed breeds ranging in age from three months to three years were used in the study. They were vaccinated against canine distemper and infectious canine hepatitis (Cabvac, American Cyanamid Corp.) upon arrival.
Six guinea pigs weighing 350 to 400 grams each were employed for the preparation of immune serum against Penn/343/67.
Housing of dogs for inoculation and contact studies. The dogs were kept in the Animal Housing Facilities of the University of Pennsylvania Interdisciplinary Cancer Research Unit. Upon arrival they were placed in isolation rooms where they stayed for at least three weeks prior to the start of the infectivity experiments. Twenty-four hours before inoculation, dogs to be directly exposed to the virus (group A) were moved to another isolation room which had been freshly disinfected. Twenty-four (experiment I) or six days (experiment II) after viral inoculation, new dogs to serve as contacts (group B) were paired with the group A animals. Eleven (experiment I) or five (experiment II) days thereafter, dogs in group B were separated from the group A animals and paired with another set of dogs which were to serve as secondary contacts (group C) and which were kept in a separate room also in the isolation area. Control dogs (group D) were maintained in another room outside of the area, as sentinels for accidental introduction of another infectious agent into the facility.
Cortisone treatment. Several dogs in the direct inoculation, contact and control groups received daily intramuscular injections of cortisone acetate at a dosage of about 5 mg per lb body weight. The treatment was started two days prior to and was continued until 10 days after experimental exposure to the virus. . Inoculation of dogs with Penn/348/67. After a fasting period of 24 hours, dogs in group A were moderately anesthetized by an intravenous injection of sodium thiamylal (Surital (Park, Davis &Co.)). Two ml of virus suspension containing about 10 5 TCID 5 o per ml was then sprayed into the throat by means of a DeVilbis atomizer #15 and 0.5 ml of the same suspension was dropped into each nostril. The dogs were not fed until at least 6 hours later. All inoculations were carried out under a hood.
Vinos isolation attempts. Nasopharyngeal specimens for virus isolation were collected on a sterile swab (Calgiswabs, COLAB) and placed in tubes containing 3 ml of brain-heart infusion broth supplemented with 1000 units penicillin, 500 meg streptomycin, 5 meg of amphotericin B (Fungizone) per ml and gelatin to give a final concentration of 0.5 per cent. After removal of the swabs and centrifugation at 1000 rpm for 10 minutes, 0.2 ml of the clarified fluids were inoculated into each of four tubes containing monolayers of MDCK cells. At the end of six to eight days of incubation in a stationary position at 36 C the monolayers were examined for evidence of hemadsorption. Specimens which showed no hemadsorption on first passage were subpassed once more before being declared negative.
Collection and processing of canine sera. Serum specimens were obtained from all dogs when first received, before the experiments were started and at varying intervals after exposure to Penn/343/67 virus. They were inactivated at 56 C for 30 minutes and stored at -20 C until tested.
Nonspecific hemagglutinins were removed by adsorbing the sera with guinea pig erythrocytes. For the removal of nonspecific inhibitors of hemagglutination, the serum samples used for antigenic analysis were treated with receptor destroying enzyme (RDE) followed by adsorption with guinea pig cells.
All samples drawn from the same dog at different time intervals were assayed simultaneously by a given test procedure.
Serologic studies. The development of antibodies to Penn/343/67 virus in the experimental dogs was studied by the hemagglutination inhibition (HI) and hemadsorption-neutralization (HAD-N) tests. Antigenic analysis of Penn/343/67 virus was conducted by means of reciprocal HAD-N and HI tests. The prevalence of antibodies to Penn/343/67 virus was measured by the HAD-N test.
Reference antiserum to Penn/343/67 virus was prepared by intranasal inoculation of guinea pigs with 0.3 ml of a clarified suspension of Penn/343/67 virus containing 10 5 -5 TCID 50 per ml followed in two weeks by an intraperitoneal booster dose of 1 ml of the same virus suspension. The inoculated animals as well as non-infected controls were bled prior to-inoculation and at intervals between one and three weeks after the booster injection. Sera obtained from these bleedings were heat inactivated and stored at -20 C until tested. Sendai antiserum was similarly prepared in our laboratories. Reference antisera to SV5, PI-1 (HA 2), PI-2 (CA), PI-3 (HA 1), and mumps viruses were purchased from Microbiological Associates, Bethesda, Maryland. Newcastle disease hyperimmune serum was obtained from Lederle Laboratories. The reference viruses have been described above.
HI test. Hemagglutination titrations (HA) and assaying of sera for HI antibodies were performed in plastic microplates according to recommended methods (20) .
The Penn/343/67 and SV5 antigens were prepared from infected cell cultures of MDCK and LLC-MK 2 , respectively, following standard procedures (20) . Sendai, mumps and Newcastle disease HA antigens were prepared from infected allantoic fluids. Antigens for the parainfluenza human types 1, 2 and 3 agents were purchased from Microbiological Associates.
HAD-N test. For the determination of hemadsorption neutralizing antibodies, serial twofold dilutions of sera were tested against approximately 100 TCID 50 of virus according to standard techniques (20) . The test with PI-1 virus was performed in AGMK cell cultures and with all the other viruses in LLC-MK2 cell cultures. (table 1) . The two animals from which virus could not be isolated had high levels of pre-existing antibodies (1:256) in contrast to the lack of such antibodies in the successfully infected animals. Virus shedding commenced 24 to 48 hours after inoculation and persisted for five to seven days thereafter. Of eight other dogs placed in contact with the inoculated animals 24 hours after inoculation, again only the five which did not have pre-existing antibodies yielded virus. In this group virus shedding started two to five days after exposure and also lasted for five to seven days. All five showed significant antibody increases. The three dogs with pre-existing antibody (1:256-1:1024) failed to yield virus. A third group of eight dogs without antibody which were placed with the primary contacts after virus shedding ceased, i.e., 11 days after the latters' exposure, failed to become infected. Four of the eight dogs in each of the three groups were given cortisone. This treatment had no apparent effect on the establishment of infection or the duration of virus shedding.
EXPERIMENTAL RESULTS

Inactivity and transmission. Six of the eight dogs which were inoculated in the first
Since the possibility existed that infection of the primary contacts described above could have been mediated by residual virus remaining in the air or on the coats of the inoculated animals and not by replicating virus, a second study was carried out in which primary and secondary contacts were exposed at a later time in the course of the experiment. Thus in experiment II primary contacts were exposed to the directly inoculated animals six days after inoculation. All of the inoculated animals, none of which possessed pre-existing antibody, were readily infected, as were their two antibodyfree primary contacts. Five days after the primary contacts' exposure, the latter were brought to another room and paired with four new antibody-free dogs; all four of these secondary contacts also become infected. The patterns of virus shedding and antibody rises in the inoculated and contact dogs were the same as observed in the initial experiment. In all instances, in both experiments, virus recovery was accomplished on first passage in MDCK cell cultures and the isolates were found to be identical with that administered. No virus was recovered from the antibody-free sentinel control dogs and none of them showed antibody increases.
Influence of experimentally induced specific antibody on infection.
Four dogs successfully infected in experiment I by either inoculation or contact and two which had had antibodies prior to that experiment and which presumably therefore did not become infected, were challenged with Penn/343/67 virus 70 days after their original exposure. At the time, all possessed neutralizing antibody titers of 1:64 to 1:1024. Although four antibody-free dogs, which were challenged simultaneously with the same virus, became infected, as revealed by virus recovery and the development of specific antibody, no virus could be isolated from those with antibody. However, five of the latter sustained fourfold or greater elevations in their antibody levels as will be described below.
Clinical and radiologic signs. All dogs were examined daily for seven days before and 15 days after exposure to virus for: (a) rises in rectal temperature; (b) cough reflex (elicitation by mild external manipulation of the trachea); (c) spontaneous cough; (d) conjunctivitis; (e) nasal discharge; and (f) pharyngitis and tonsillitis. Because considerable individual variations in daily temperatures were found during the sevenday period prior to exposure, only increases of 1.4 F or greater over the previous day were considered significant. Since manipulation of the trachea sometimes elicited a weak, sporadic cough in control, in non-infected, as well as in infected dogs, such responses were not taken as a sign of disease. Only long-lasting, often paroxysmal, cough reflexes thus produced were considered positive. A mild watery nasal discharge and/or pharyngitis was seen in several of the resistant dogs. These conditions could have been due to irritation caused by daily swabbing. Thus only intensive and persistent rhinorrhea and/or pharyngitis were considered positive. Sixteen infected and two non-infected control dogs were radiographed. Those presenting the most evident clinical signs of respiratory disease were generally selected for an acute stage x-ray examination. Pre-exposure radiographs were taken of five of the 16 infected animals.
The clinical and radiologic findings are given in tables 2 and 3, respectively. Where fever was detected, it generally started on the day of, or day before, virus shedding and persisted for 24 hours. Cough elicited by massage generally was noted several days before the appearance of spontaneous cough. The latter was never observed before seven days after exposure and lasted between two and 12 or more days. In some dogs a positive cough reflex could be elicited for as long as four weeks after exposure. In the three animals which developed a marked nasal discharge, it was serous and lasted for three to more than 15 days. Intensive pharyngitis was generally accompanied by erythema and hypertrophy of the tonsils.
Radiologic signs of respiratory disease varied from bronchial wall thickening with hypervascularization (pneumonitis) (figure 1) to diffuse consolidation with air bronchogram (pneumonia) (figure 2) which contrasted with the normal findings evident in the pre-exposure radiographs ( figure 3) .
Pathologic changes. Gross pathologic alteration of the lungs was found in five of seven dogs sacrificed between 14 and 20 days after infection by inoculation or by contact. The visible lesions consisted of scattered firm, dull, gray-greenish areas on the surface or near or surrounding the bifurcation of the main bronchi. In two of these five animals (dogs #33 and 88, group C-II) frank consolidation also was seen in the lungs on cross-section. The lesions were not restricted to any particular lobe and varied in size from 1 mm to 4-5 cm in diameter.
Scattered pale nodules, about 1 mm in diameter, were found on the pleural surface of the lungs of two dogs sacrificed 107 days after exposure. In one of these dogs, an elongated pale scar about 1 cm in length also was visible at the origin of the left cardiac lobe bronchus. Distal to it was a firm gray-green lesion similar to those described for the animals sacrificed 14 to 20 days after exposure.
Hematoxylin-eosin stained histologic sections were prepared from the lungs of each of the sacrificed dogs. Microscopic examination of tissues taken 14 to 20 days after exposure revealed the presence of: interstitial pneumonia (figures 4 and 5) with mononuclear cell infiltration in one directly inoculated and a secondary contact dog (dog #4, group A-II; dog #88, group C-II); severe bronchitis and bronchopneumonia (figure 6) with areas of hepatization and diffuse neutrophilic inflammation in another secondary contact dog (dog #33, group C-II) and similar but less extensive lesions in two primary contacts (dogs #22 and #55, group B-II). Dog #55 also showed evidence of bronchiolitis. In two other directly inoculated animals, only an active hyperemia was seen (dogs #8 and #9, group A-II). Of the two dogs sacrificed 107 days after their initial exposure, one animal (dog #10, group B-I) still showed evidence of interstitial pneumonia while the other (dog #5, group B-I) which was re-challenged by nasopharyngeal administration of virus 35 days previous to sacrifice, showed an area of reparative pneumonia. In two other contact-exposed dogs (#44 and #99, group fill) with pre-existing antibody and which did not become infected, no active pathologic changes were discernible.
Influence of cortisone. As already indicated, cortisone treatment did not enhance the initiation of infection or duration of virus shedding. Similarly, no apparent difference was noted between treated and nontreated animals in the development of clinical or radiological signs of disease. However, the antibody responses to infection were somewhat lower in the cortisonetreated dogs. Thus, by 30 days after infec : tion, when the neutralizing antibody titers reached their peak, the geometric mean values were 1:445 for the nontreated and 1:167 for the treated dogs. By three months two weeks and attained their highest levels by 21 days. They were still evident at considerable levels at three months.
Although no virus could be recovered from .experimental dogs with natural or experimentally induced pre-existing antibodies, several responded with antibody increases following exposure to Penn/343/67 virus. The HI test findings are given in table 6. The HAD-N test results ran in parallel.
Development of antibodies to heterologous parainfluenza virus strains. Paired serum samples taken just before and 30 days after exposure to Penn/343/67 virus by inoculation or by contact were examined for antibodies to PI-1 (HA 2), PI-2 (CA), PI-3 (HA-1) and SV5 viruses. The HI test results on sera from experiment I are presented in table 7. It can be seen that antibodies to the human PI-1, PI-2 and PI-3 strains were not detected in any of these sera. However, where pre-existing antibodies to Penn/343/67 virus occurred, similar levels of antibodies to SV5 virus also were present. Following infection all but one dog developed antibodies to SV5 virus along with antibodies to the experimental strain. In several animals, the heterologous titers tended to be somewhat lower than the homologous titers. Similar results were obtained with the sera of experiments II and III.
Antigenic relationships of Penn/843/67 virus with other paramyxoviruses. On comparing the antigenic composition of Penn/ 343/67 virus with other paramyxoviruses by reciprocal HAD-N tests (table 8) , it becomes evident that the canine strain shared antigens with SV5 and to a lesser extent with mumps virus and that by employing mono-infection sera, Penn/343/67 was clearly distinguishable from SV5 virus. For example, hyperimmune serum prepared against either Penn/343/67 or SV5 neutralized both viruses to the same extent. However, with selected sera from some experimental dogs, 8-to 16-fold higher titers were detected with the homologous Penn/343/67 Downloaded from https://academic.oup.com/aje/article-abstract/94/2/147/167124 by guest on 10 January 2019 virus than with the SV5 strain. Cross-reactions with mumps virus were observed with antisera against both Penn/343/67 and SV5 viruses but to a lower degree. Furthermore, the reciprocal reaction was not found to occur, i.e., with mumps antiserum and the Penn/343/67 and SV5 viruses. A barely detectible cross-reaction was noted only between SV5 hyperimmune serum and PI-2 virus. The high titers observed with the Sendai serum and the SV5 and Penn/343/67 viruses probably reflected past infection of the donor guinea pig with a SV5 agent, for it is difficult to find guinea pig colonies free of such infections. Isolates from two of the infected dogs (dog #14, group A-I and dog #6, group B-I) showed identical reactions as the original Penn/343/67 virus.
Similar relationships between Penn/343/ 67 and SV5 viruses and between both these agents and mumps virus were also revealed by reciprocal HI tests (table 9) . In addition, cross-reactions with PI-2 virus were more apparent by HI, i.e. when hyperimmune sera prepared against Penn/343/67 and SV5 viruses were tested with the human virus. Although the PI-2 antiserum also showed fairly good cross-reactions with the SV5 and Penn/343/67 antigens, their significance is unclear. The PI-2, as well as the PI-1 and PI-3 antisera used in the HI were unfortunately different from those used in the HAD-N tests. The possibility thus exists that they, like the Sendai serum, came from SV5 virus infected guinea pigs.
Prevalence of neutralizing antibodies to Penn/348/67 virus in a nonselected canine population. Serum samples of 60 nonselected dogs which had been admitted to the --16  32   14   96  128  --64  191  178  64  128  89   evels on days after exposure   21   178  315  355  512  128  191  ----30   256  158  --331  128  ----70   78  50  --72   50  ----80   45  ---50  ----90   38  ---50  ----100   52  ---50 ---* 0 = <8. t 0 = <32. The Penn/343/67 agent was originally isolated from a dog with signs of tracheobronchitis. The dog yielding the virus and a sick companion animal in the same outbreak of kennel cough, showed rises in specific antibodies. Clearly, from the results presented here, this parainfluenza virus must have been responsible for the disease noted, for under experimental conditions it could infect and produce respiratory disease in other dogs. When introduced into the nose and throat, it not only was capable of establishing active infection in 100 per cent of the animals without pre-existing antibodies to the agent, as revealed by virus recovery and development of specific antibody, but it could be transmitted spontaneously to other antibody-free primary and secondary contact dogs. Furthermore, transmission could be correlated directly with the period of virus shedding which appeared after a one-to five-day incubation period and lasted for five to eight days. The slightly longer incubation period which was observed in contact dogs most likely could have been related to the smaller dose avail- ection and ranged from marked rhinorrhea and pharprotected yngitis to bronchitis, bronchiolitis and o infective pneumonia. The incidence and severity of urrent sue-the illness produced seemed to have been irus of all greater in the primary and secondary confact that tacts than in the inoculated animals. But earing anti-unfortunately the number of animals comreases. The prising each group was too small to permit ing intro-the conclusion that successive passages of harynx un-the virus in dogs increased its virulence. ltiplication With respect to the lung changes which 2). Under were observed by x-ray in some of the resisdoubtedly tant animals, it must be realized that most ucing cells of the dogs used in the study were purh produce chased as "conditioned." The "conditionThat anti-ing" of dogs undoubtedly encompasses, to a quently in large extent, experience with a virus identihan natur-cal or related to the Penn/343/67 agent have been (23) . It is very likely, therefore, that the had higher radiologic as well as the antibody findings animals it in these animals reflected a recent infection creases. with such a virus. ere elicited Stress has been found to be an important d animals, contributing cause of respiratory disease ed in out-outbreaks in lower animals from which par-, 1) lasted ainfluenza viruses have been isolated (24, eeks. Aside 16, 25) . A number of investigators, in ation caused tempting to simulate stress, reported that haryngitis doses of cortisone similar to those given to frequently 50 per cent of the dogs in experiment I ogs. How-greatly enhanced the susceptibility of labobserved in ratory animals to viral infections (26) . In rayed with this study, cortisone was not observed to imals sus-affect the susceptibility of the dogs nor the e assumed severity of the disease produced as a result ltiplication of infection. Nevertheless, it did tend to deas uptake press the levels of antibodies evoked, but phoid cells apparently not sufficiently to interfere with he inflam-control of the disease process. Depression of is felt that antibody responses by cortisone has been ne are not noted by others (26) . of disease Because of time and space limitations, ame clear, the persistence of antibodies in the experipathologic mental dogs could be followed for only 3 to inations of 3 ! /2 months. It was of interest to discover ct dogs in that although in both the inoculated and multiplied, contact infected animals, HI and HAD-N volvement antibodies sometimes appeared during the se picture early part of the second week (eight to 11 Downloaded from https://academic.oup.com/aje/article-abstract/94/2/147/167124 by guest on 10 January 2019 days), the HI titers reached their peak between 14 and 21 days and the HAD-N titers at about 30 days after exposure. Evidently then these two antibodies are not the same, and as suggested by differences in their specificities, (sec below) they do not reflect reactions to identical portions of the virion capsid. Subsequently, both antibodies decreased somewhat, but were still present at considerable levels at the termination of the study.
The small investigation of the prevalence of serum-neutralizing antibodies to Penn/ 343/67 virus in a nonselected dog population revealed the incidence to be about 28 per cent. The geometric mean titer of the positives was 5:1:53, i.e., about the same as observed in the experimental dogs 100 days after exposure. However, since there is no information with respect to persistence and levels of these antibodies beyond 3!/2 months it is difficult to guess when the positive dogs might have sustained their infection and more important, whether the negative dogs still might not have been infected in the distant past with subsequent antibody decline to below measurable levels. Certainly more extensive studies of antibody persistence and of evidence of infection in closed and open populations obtained through virus isolation and/or antibody assays, must be made before conclusions regarding the incidence of infection with this virus among canines can be determined.
If continuing investigations reveal that a parainfluenza virus, identical or related to Penn/343/67 virus, is indeed a relatively significant cause of respiratory disease in dogs, that the presence of circulating antibodies may be taken as a measure of resistance to natural infection, and that such antibodies persist for a reasonable length of time, then the development of a vaccine to control the disease might be indicated.
To date, it has not been determined whether the Penn/343/67 virus is the same or different from the SV5-like viruses isolated by Binn et al. (2, 15) and by Crandell et al. (16) . In more recent studies a series of isolates, some identical with and others slightly different from Penn/343/67 virus, but also SV5-like were recovered from several separate epizootics. Their further characterization including a comparison with Binn's virus is in progress. In any event, antigenic comparison of the Penn/343/67 virus with other prototype paramyxoviruses revealed that, although closely related to, it was distinguishable from SV5 virus when examined by the HAD-N or HI tests employing monoinfection serum. Like SV5 virus it also was found to share a minor antigen with mumps virus. A relationship of Penn/343/67 virus with parainfluenza 2 virus, however, could not be detected by HAD-N although a very meager cross reaction between SV5 and parainfluenza 2 virus was observed by this test. By HI procedures, both viruses were found to cross with parainfluenza 2, but again only to a limited extent. Hsiung (27) also reported finding only low levels of cross-reactions between SV5 and the related DA agent with parainfluenza 2 virus. Whether these results warrant removing the simian and human as well as the canine agents from the parainfluenza 2 group where they were originally placed (28) and reclassifying them as parainfluenza 5 as suggested by Hsiung remains a moot point.
As already indicated, the detection in the Sendai PI-1, PI-2 and PI-3 guinea pig antisera of antibodies which cross-reacted with SV5 and Penn/343/67 viruses does not imply that the former four viruses also bear a relationship to SV5 and the canine strains. More than likely, they reflected the frequent SV5 infections which occur in guinea pig colonies. Similarly, the low reaction of the Penn/343/67 guinea pig serum with Sendai virus could have resulted from a latent Sendai infection which also occurs occasionally in this species (29) . The crossreactions noted by HI among the strains of human origin were to be expected especially since the test sera were prepared by hyperimmunization (30, 31) .
To date, there is no evidence that SV5 virus, which repeatedly appears in ostensibly normal monkey kidney cell cultures, is linked to disease in that species. Furthermore, antibodies to the virus usually appear in monkeys only after they have been held for a while in captivity (32) . The question arises as to whether some other species, perhaps canines, serve as a source for the inapparent infection of simians. These observations plus the results reported here and the purported past (27, 33, 34) and recent findings (35) of SV5-like viruses in humans, suggest that the SV5-like canine agents deserve further study.
